Home » Raptor: Pain Relief Compound Proves Effective in Trial
Raptor: Pain Relief Compound Proves Effective in Trial
Development stage biotechnology company Raptor Pharmaceuticals Corp. said that its orally administered pain relief compound NGX426 proved effective in
a variety of neuropathic pain states, citing positive data from a clinical trial.
RTTNews
RTTNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May